Ipsen’s Research & Development comprises both new molecule development programs and lifecycle management programs for our existing products. During preclinical and clinical development, early identification of therapeutic targets and markers helps researchers to better define the potential value of molecules. This speeds up the process of drug development and drug approval application procedures.

Ipsen’s R&D aims to discover and develop new molecules or new formulations and indications for products already marketed.
Discover the pipeline on the Group website here

Last update 13/04/2017